Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Text availability
Article attribute
Article type
Publication date

Search Results

101 results
Filters applied: . Clear all Results are displayed in a computed author sort order. Results by year timeline is unavailable
Page 1
Phase II trial of tipifarnib plus neoadjuvant doxorubicin-cyclophosphamide in patients with clinical stage IIB-IIIC breast cancer.
Sparano JA, Moulder S, Kazi A, Coppola D, Negassa A, Vahdat L, Li T, Pellegrino C, Fineberg S, Munster P, Malafa M, Lee D, Hoschander S, Hopkins U, Hershman D, Wright JJ, Kleer C, Merajver S, Sebti SM. Sparano JA, et al. Clin Cancer Res. 2009 Apr 15;15(8):2942-8. doi: 10.1158/1078-0432.CCR-08-2658. Epub 2009 Apr 7. Clin Cancer Res. 2009. PMID: 19351752 Free PMC article. Clinical Trial.
Update on the management of advanced breast cancer.
Fornier M, Munster P, Seidman AD. Fornier M, et al. Oncology (Williston Park). 1999 May;13(5):647-58; discussion 660, 663-4. Oncology (Williston Park). 1999. PMID: 10356685 Review.
New drugs in gynecologic cancer.
Daud A, Munster P, Munster P, Spriggs DR. Daud A, et al. Curr Treat Options Oncol. 2001 Apr;2(2):119-28. doi: 10.1007/s11864-001-0054-0. Curr Treat Options Oncol. 2001. PMID: 12057130 Review.
Role of taxanes in adjuvant therapy.
Münster PN, Hudis CA. Münster PN, et al. Cancer Invest. 2000;18(1):32-8. doi: 10.3109/07357900009023060. Cancer Invest. 2000. PMID: 10701365 Review. No abstract available.
101 results
You have reached the last page of results. A maximum of 10,000 results are available.
Jump to page